CLINICAL RESEARCH: HEART RHYTHM DISORDER
Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation
Riccardo Cappato, MD*,*,
Hugh Calkins, MD ,
Shih-Ann Chen, MD ,
Wyn Davies, MD ,
Yoshito Iesaka, MD||,
Jonathan Kalman, MD¶,
You-Ho Kim, MD#,
George Klein, MD**,
Andrea Natale, MD ,
Douglas Packer, MD and
Allan Skanes, MD**
* Arrhythmias and Electrophysiology Center, I.R.C.C.S. Policlinico San Donato, Milan, Italy
Johns Hopkins University School of Medicine, Baltimore, Maryland
Veterans General Hospital, Taipei, Taiwan
St. Mary's Hospital, London, United Kingdom
|| Cardiovascular Center, Tsuchiura Kyodo Hospital, Tsuchiura, Ibaraki, Japan
¶ Royal Melbourne Hospital, Parkville, Victoria, Australia
# Cardiology Department, Asan Medical Center, Seoul, South Korea
** Department of Cardiology, University Hospital, London, Ontario, Canada
 Texas Arrhythmia Institute, St. David's Medical Center, Austin, Texas
 Division of Cardiology, Mayo Foundation–St. Mary Hospital, Rochester, Minnesota
Manuscript received November 12, 2008;
revised manuscript received January 6, 2009,
accepted February 13, 2009.
* Reprint requests and correspondence: Dr. Riccardo Cappato, Arrhythmia and Electrophysiology Center, Policlinico San Donato, Via Morandi 30, San Donato Milanese, 20097 Milan, Italy (Email: rcappato{at}libero.it).
Objectives: The purpose of this study was to provide a systematic multicenter survey on the incidence and causes of death occurring in the setting of or as a consequence of catheter ablation (CA) of atrial fibrillation (AF).
Background: CA of AF is considered to be generally safe. However, serious complications, including death, have been reported.
Methods: Using a retrospective case series, data relevant to the incidence and cause of intra- and post-procedural death occurring in patients undergoing CA of AF between 1995 and 2006 were collected from 162 of 546 identified centers worldwide.
Results: Thirty-two deaths (0.98 per 1,000 patients) were reported during 45,115 procedures in 32,569 patients. Causes of deaths included tamponade in 8 patients (1 later than 30 days), stroke in 5 patients (2 later than 30 days), atrioesophageal fistula in 5 patients, and massive pneumonia in 2 patients. Myocardial infarction, intractable torsades de pointes, septicemia, sudden respiratory arrest, extrapericardial pulmonary vein (PV) perforation, occlusion of both lateral PVs, hemothorax, and anaphylaxis were reported to be responsible for 1 death each, while asphyxia from tracheal compression secondary to subclavian hematoma, intracranial bleeding, acute respiratory distress syndrome, and esophageal perforation from an intraoperative transesophageal echocardiographic probe were causes of 1 late death each.
Conclusions: Death is a complication of CA of AF, occurring in 1 of 1,000 patients. Knowledge of possible precipitating causes is key to operators and needs to be considered during decision making with patients.
Key Words: atrial fibrillation catheter ablation supraventricular radiofrequency pulmonary vein
|
Abbreviations and Acronyms
| | AF = atrial fibrillation | | CA = catheter ablation | | EP = electrophysiology | | PV = pulmonary vein | | RF = radiofrequency | | SV = supraventricular | | TEE = transesophageal echocardiographic |
|
Related Articles
-
A 1 Per 1,000 Mortality Rate After Catheter Ablation of Atrial Fibrillation: An Acceptable Risk?
- Bernard Belhassen
J. Am. Coll. Cardiol. 2009 53: 1804-1806.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A30.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
D. Lakkireddy, Y. M. Reddy, L. Di Biase, S. R. Vanga, P. Santangeli, V. Swarup, R. Pimentel, M. C. Mansour, A. D'Avila, J. E. Sanchez, et al.
Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation: Results From a Multicenter Prospective Registry
J. Am. Coll. Cardiol.,
February 1, 2012;
(2012)
j.jacc.2011.12.014v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Haggerty, T. J. George, G. J. Arnaoutakis, C. J. Barreiro, A. S. Shah, and M. S. Sussman
Successful Repair of an Atrioesophageal Fistula After Catheter Ablation for Atrial Fibrillation
Ann. Thorac. Surg.,
January 1, 2012;
93(1):
313 - 315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-T. CHAO, T. CALLAHAN, and B. BARANOWSKI
Atrial fibrillation management: Issues of concern (APRIL 2011)
Cleveland Clinic Journal of Medicine,
November 1, 2011;
78(11):
720 - 720.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sorgente, G.-B. Chierchia, C. de Asmundis, A. Sarkozy, L. Capulzini, and P. Brugada
Complications of atrial fibrillation ablation: when prevention is better than cure
Europace,
November 1, 2011;
13(11):
1526 - 1532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zellerhoff, F. Lenze, and L. Eckardt
Prophylactic proton pump inhibition after atrial fibrillation ablation: is there any evidence?
Europace,
September 1, 2011;
13(9):
1219 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. St. Julien, J. B. Putnam Jr, J. C. Nesbitt, E. S. Lambright, M. R. Petracek, and E. L. Grogan
Successful Treatment of Atrioesophageal Fistula by Cervical Esophageal Ligation and Decompression
Ann. Thorac. Surg.,
June 1, 2011;
91(6):
e85 - e86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Kim, S. S. Johnston, B.-C. Chu, M. R. Dalal, and K. L. Schulman
Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States
Circ Cardiovasc Qual Outcomes,
May 1, 2011;
4(3):
313 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hakalahti, P. Uusimaa, K. Ylitalo, and M. J. P. Raatikainen
Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment
Europace,
May 1, 2011;
13(5):
640 - 645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tanner, K. Makowski, L. Roten, J. Seiler, N. Schwick, C. Muller, J. Fuhrer, and E. Delacretaz
Catheter ablation of atrial fibrillation as first-line therapy--a single-centre experience
Europace,
May 1, 2011;
13(5):
646 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Piorkowski, C. Eitel, S. Rolf, K. Bode, P. Sommer, T. Gaspar, S. Kircher, U. Wetzel, A. S. Parwani, L.-H. Boldt, et al.
Steerable Versus Nonsteerable Sheath Technology in Atrial Fibrillation Ablation: A Prospective, Randomized Study
Circ Arrhythm Electrophysiol,
April 1, 2011;
4(2):
157 - 165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Nguyen, Z. J. Wang, V. Vedantham, and N. Badhwar
Odynophagia After Atrial Fibrillation Ablation
Circulation,
March 1, 2011;
123(8):
e253 - e254.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Shah, H. Lambert, A. Langenkamp, Y. Vanenkov, G. Leo, P. Gentil-Baron, and B. Walpoth
Catheter tip force required for mechanical perforation of porcine cardiac chambers
Europace,
February 1, 2011;
13(2):
277 - 283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zellerhoff, L. Eckardt, and P. Kirchhof
A real-time tip manometer for radiofrequency catheter ablation: new toy or useful tool?
Europace,
February 1, 2011;
13(2):
159 - 160.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Govindan, I. Savelieva, A. Catanchin, and A. J. Camm
Atrial Fibrillation-The Final Frontier
Journal of Cardiovascular Pharmacology and Therapeutics,
December 1, 2010;
15(4_suppl):
36S - 50S.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Kramer and M. E. Josephson
Three Questions for Evidence-Based Cardiac Electrophysiology
Circ Cardiovasc Qual Outcomes,
November 1, 2010;
3(6):
704 - 709.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hargrove, C. Marshall, S. Jahanjir, and J. Hinchion
Emergency bypass post percutaneous atrial ablation: a case report
Perfusion,
November 1, 2010;
25(6):
423 - 424.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. J. Chun, E. Wissner, B. Koektuerk, M. Konstantinidou, B. Schmidt, T. Zerm, A. Metzner, R. Tilz, S. Boczor, A. Fuernkranz, et al.
Remote-Controlled Magnetic Pulmonary Vein Isolation Using a New Irrigated-Tip Catheter in Patients With Atrial Fibrillation
Circ Arrhythm Electrophysiol,
October 1, 2010;
3(5):
458 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Developed with the special contribution of the Eur, Endorsed by the European Association for Cardio-Th, Authors/Task Force Members, A. J. Camm, P. Kirchhof, G. Y. H. Lip, U. Schotten, I. Savelieva, S. Ernst, I. C. Van Gelder, et al.
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
Eur. Heart J.,
October 1, 2010;
31(19):
2369 - 2429.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Leong-Sit, E. Zado, D. J. Callans, F. Garcia, D. Lin, S. Dixit, R. Bala, M. P. Riley, M. D. Hutchinson, J. Cooper, et al.
Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of Age
Circ Arrhythm Electrophysiol,
October 1, 2010;
3(5):
452 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Developed with the special contribution of the Eur, Endorsed by the European Association for Cardio-Th, Authors/Task Force Members, A. J. Camm, P. Kirchhof, G. Y. H. Lip, U. Schotten, I. Savelieva, S. Ernst, I. C. Van Gelder, et al.
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
Europace,
October 1, 2010;
12(10):
1360 - 1420.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cazavet, F. Muscari, M. A. Marachet, and B. Leobon
Successful surgery for atrioesophageal fistula caused by transcatheter ablation of atrial fibrillation
J. Thorac. Cardiovasc. Surg.,
September 1, 2010;
140(3):
e43 - e45.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Hunter and R. J. Schilling
Long-term outcome after catheter ablation for atrial fibrillation: safety, efficacy and impact on prognosis
Heart,
August 1, 2010;
96(16):
1259 - 1263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kirchhof and L. Eckardt
Ablation of atrial fibrillation: for whom and how?
Heart,
August 1, 2010;
96(16):
1325 - 1330.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bottoni, M. Tritto, R. Ricci, M. Accogli, M. Di Biase, S. Iacopino, M. Iori, S. Themistoclakis, N. Sitta, G. Spadacini, et al.
Adherence to guidelines for atrial fibrillation management of patients referred to cardiology departments: Studio Italiano multicentrico sul Trattamento della Fibrillazione Atriale (SITAF)
Europace,
August 1, 2010;
12(8):
1070 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Siegel, D. M. Parenti, and G. L. Simon
Atrial-Esophageal Fistula after Atrial Radiofrequency Catheter Ablation
Clinical Infectious Diseases,
July 1, 2010;
51(1):
73 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Di Biase, J. D. Burkhardt, P. Mohanty, J. Sanchez, R. Horton, G. J. Gallinghouse, D. Lakkireddy, A. Verma, Y. Khaykin, R. Hongo, et al.
Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation: The Impact of Periprocedural Therapeutic International Normalized Ratio
Circulation,
June 15, 2010;
121(23):
2550 - 2556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. B. Tedrow, D. Conen, P. M. Ridker, N. R. Cook, B. A. Koplan, J. E. Manson, J. E. Buring, and C. M. Albert
The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation: The WHS (Women's Health Study)
J. Am. Coll. Cardiol.,
May 25, 2010;
55(21):
2319 - 2327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Nault, S. Miyazaki, A. Forclaz, M. Wright, A. Jadidi, P. Jais, M. Hocini, and M. Haissaguerre
Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation
Eur. Heart J.,
May 1, 2010;
31(9):
1046 - 1054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Knight
Transesophageal Echocardiography Before Atrial Fibrillation Ablation: Looking Before Cooking
J. Am. Coll. Cardiol.,
November 24, 2009;
54(22):
2040 - 2042.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Wyse
Cardioversion of Atrial Fibrillation for Maintenance of Sinus Rhythm: A Road to Nowhere
Circulation,
October 6, 2009;
120(14):
1444 - 1452.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Ablation for Atrial Fibrillation: Not Risk Free
Journal Watch Cardiology,
May 27, 2009;
2009(527):
1 - 1.
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Belhassen
A 1 Per 1,000 Mortality Rate After Catheter Ablation of Atrial Fibrillation: An Acceptable Risk?
J. Am. Coll. Cardiol.,
May 12, 2009;
53(19):
1804 - 1806.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst
CHAPTER 29 Atrial Fibrillation
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|